Janssen, Pfizer to supply anti-depressants in KoreaJanssen Korea, a pharmaceutical subsidiary of Johnson & Johnson, said yesterday that it established a strategic partnership with Pfizer Korea Monday to promote Pfizer’s depression treatment Efexor XR.
Efexor XR is the first anti-depressant of the serotonin-norepinephrine reuptake inhibitor (SNRI) class launched in Korea. Pfizer Korea is responsible for manufacturing, importing and distributing the drug while Janssen Korea is responsible for promotion. “This strategic partnership will allow the two companies to make contributions to improving the quality of life for patients with depressive disorders,” said Kim Oak-yeon, Janssen Korea’s chief executive.
More in Industry
Luxury loungewear is no longer just for lounging
KGC to work on a ginseng-based vaccine adjuvant
Hanwha Techwin continues selling CCTV systems overseas
Popeyes to close all branches in Korea this month
Contract signed for Covid-19 vaccine